TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
155 hedge funds and large institutions have $1.24B invested in Turning Point Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 66 increasing their positions, 53 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less capital invested
Capital invested by funds: $2.15B → $1.24B (-$905M)
98% less call options, than puts
Call options by funds: $5K | Put options by funds: $236K
Holders
155
Holding in Top 10
2
Calls
$5K
Puts
$236K
Top Buyers
| 1 | +$22.7M | |
| 2 | +$18.1M | |
| 3 | +$10.7M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$9.17M |
| 5 |
Morgan Stanley
New York
|
+$6.35M |
Top Sellers
| 1 | -$29.3M | |
| 2 | -$26.1M | |
| 3 | -$15.6M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$11.9M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$9.16M |